SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-277116
Filing Date
2012-06-20
Accepted
2012-06-20 16:31:01
Documents
4
Period of Report
2012-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d369734d8k.htm 8-K 17993
2 AGREEMENT AND PLAN OF MERGER d369734dex21.htm EX-2.1 32566
3 ARTICLES OF INCORPORATION d369734dex31.htm EX-3.1 152625
4 BYLAWS OF LJPC CALIFORNIA d369734dex32.htm EX-3.2 65113
  Complete submission text file 0001193125-12-277116.txt   269398
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 12917650
SIC: 2836 Biological Products, (No Diagnostic Substances)